Live-streamed to over 600 delegates from AstraZeneca’s new R&D Centre in Cambridge, UK, this year’s BioBeat Summit focused on optimising outcomes through digital innovation in clinical trials and beyond. BioBeat founder Miranda Weston-Smith opened the event with the message that we are at our most impactful when technology and humanity converge, bringing new opportunities for creating progress and value.
We need to share our experiences about what works, to build on the valuable insights we’ve all gained over the past two years. There are still plenty of challenges to overcome but the future is bright. This year’s Summit highlighted many opportunities for our community in digitally driven clinical research and healthcare.